SUMMARY
INTRODUCTION
Intensive insulin therapy has led to significant reduction of long-term complications of diabetes (1) . However, hypoglycemia is the most frequent acute complication of this therapy (2) . Marked hypoglycemia represents a life-threatening medical emergency causing symptoms ranging from autonomic responses to seizures and coma. It is recognized to be an unfortunate ''fact of life'' for people who require insulin to maintain glycemic control, thereby, making a major limitation to intensive insulin therapy in those patients (3) . During hypoglycemia release of counter regulatory hormones especially epinephrine increased to maintain blood glucose homeostasis. This serves to correct and prevent hypoglycemia and restore euglycemia (4,5) . Most of the previous studies focused on the effect of acute hypoglycemic damage to the central nervous system (6,7,8) . The central nervous system is extremely sensitive to hypoglycemic damage, because of the properties of the hematoencephalic barrier and the lack of other substrates in the CNS (9) . Less attention has been paid to the effect of the acute hypoglycemic damage on peripheral tissues as skeletal muscles and heart. The decrease in substrate supply for energy perhaps affects those tissues as well. Furthermore, since recurrent exposure to hypoglycemia is common in patients on insulin therapy, it is less clear how recurrent hypoglycemia, as an important example of repeated physiological stressor impact at those tissues.
The presence of oxidative stress during hypoglycemia has been also suggested.
Increased fatty acid metabolism in hypoglycemia lead to acidosis, which enhances free radical aggressivity (8,10) . Hypoglycemia and oxidative stress are mostly studied as two independent stressors. Therefore, the investigation of oxidative stress during hypoglycemia is important for both understanding the mechanism of hypoglycemic organ damage and for the possible prevention of this event.
The current study was undertaken to assess the consequences of the acute and recurrent insulin-induced hypoglycemia on plasma levels of creatine kinase and lactate dehydrogenase, the markers of skeletal muscles and heart damage. In addition, to evaluate oxidative stress on those tissues and plasma epinephrine levels in response to hypoglycemia to elucidate the mechanism of hypoglycemic effect on those tissues.
MATERIALS & METHODS

Animals
The current study included a total number of 50 adult male SpragueDawley rats (age 3-5 months, weight 220-310 grams). Animals were housed and cared for in the animal house of Faculty of Medicine Assiut University under constant healthy environment, maintained on a photobic period and fed a standard chow diet supplied from the animal house. Experimental protocols were in accordance with Animal Care and Use guidelines. All experiments were initiated at 8:00 am to minimize circadian variations. Rats were randomly divided into: 1-Control group: included 10 rats received intraperitoneal (ip) injection with normal saline. 2-Acute insulin-induced hypoglycemia group (AHG group): 20 non fasted rats. The basal levels of blood glucose were determined. Rats were then injected ip with regular soluble human insulin (Humulin-R 100 IU/ml from Lilly, Egypt -Eli USA) in a dose of 10 U/kg. The dose of insulin and method of injection were chosen on the basis of data present in previous literatures (11,12) . Following insulin injection food was withheld for 6 hours. The animals had free access to water during that time. Blood glucose was measured at 30, 60, 90 and 120 min after insulin injection. Animals were then sacrificed by decapitation 6 h after insulin injection. 3-Recurrent insulin-induced hypoglycemia group (RHG group): recurrent hypoglycemia was induced by recurrent ip injection with 10 U/kg Humulin once per day for three consecutive days in 20 non fasted rats in the same fashion as for the AHG group. After 2 hours of the injection the rats were given free access to food to reverse hypoglycemia. This method was according to Herzog et al.
(12) and Fan et al.
(13) . In the fourth day rats were injected with the same dose of insulin, food was withheld for 6 hours after that animals were sacrificed by decapitation. Blood glucose was recorded before and at 30, 60, 90 and 120 min after insulin injection in the first and fourth day.
Biochemical assay:
Blood glucose: was determined in all groups using a glucometer and glucose test strips (Accutrend alphaGermany).
Plasma levels of Creatine kinase (CK) and Lactate dehydrogenase (LDH):
determined by kinetic methods (Diagnostic SystemsGmbH, Germany) before and 6 hours after the injection of either insulin or saline in AHG group, RHG group in the fourth day and in control group.
Epinephrine assay: epinephrine was measured before and 90 min after the injection (11) in all groups. It was measured in AHG group and RHG group in the first day to detect the epinephrine level in response to acute hypoglycemia. It was also measured in RHG group at the fourth day to reveal the epinephrine level in response to recurrent hypoglycemia. Epinephrine concentrations were analyzed by ELISA kit (DRG international USA-EIA-4309).
Blood samples were collected, centrifuged and the plasma were separated, stored at -20°C until determination of CK, LDH and epinephrine levels. 
RESULTS
1-Blood glucose levels before and after insulin injection: Figure 1 There were no differences among all groups in the baseline levels of blood glucose. After insulin injection the blood glucose levels dropped to statistically significant lower levels in AHG group, RHG group at day 1 and 4 when compared to control values at 30, 60, 90 and 120 min time points (p< 0,001 for all).In RHG rats at day 4 the blood glucose levels were significantly lower than those recorded on the same group at day 1 after insulin injection at the 30, 60, 90 and 120 min time points (P < 0.01). Table  1 During the baseline period, the mean values of epinephrine levels did not differ significantly between all studied groups. After 90 min of insulin or saline injection the levels measured were significantly higher than initial values in AHG group, RHG group at day 1 and in control group (P<0.001 for all). Those increased levels were significantly more pronounced in AHG and RHG group (day1) when compared to control levels (P < 0.001 for both). In RHG group at day 4, although the mean value of epinephrine levels measured 90 min after insulin injection was significantly higher than initial mean value (P < 0.001); this increased value was significantly less than that detected in control after 90 min of saline injection (P < 0.01). Table 2 The baseline mean values of plasma CK and LDH levels did not differ significantly among all groups. Insulin-induced hypoglycemia remarkably increased the plasma CK levels measured 6 hours after insulin injection in AHG group and RHG group in day 4 when compared to baseline values (P<0.001 for both) with percent increase than baseline values of 101.7% and 151% respectively. A significant increase of mean values of plasma LDH levels was also observed after 6 hours of insulin injection in AHG group and RHG group (day 4) when compared to baseline values (P< 0.001 for both). With percent increase than baseline values of 95.3% and 127.8% respectively.
Plasma epinephrine levels:
Plasma CK and LDH activity:
The levels of both enzymes detected in RHG (day 4) 6 h after insulin injection were notably greater compared to those of AHG group (P< 0.01 for both CK and LDH). The percent increase of levels of both enzymes than baseline values were also more in RHG (day 4) than those of AHG (151% versus 101.7% for CK and 127.8% versus 95.3% for LDH). In control group, the mean values of plasma levels of both CK and LDH evaluated 6 h after saline injection show slight but insignificant increase than initial values. With percent increase than baseline values of only 10.9% for CK and 16.3 % for LDH. 4. MDA and T-AOC levels in the tissues homogenate of skeletal muscle and heart: Figures 2 and 3.
Our results showed that increased lipid peroxidation in skeletal muscle and heart tissue homogenate was found in AHG and RHG group (day4) after 6 h of insulin induced hypoglycemia. This was expressed in both groups by the higher levels of MDA detected in those tissues than control levels (Fig 2) (p< 0.001 for all). Whereas, the mean values of the levels of T-AOC (Fig 3) 
Figure (1):
Blood glucose levels before and after insulin or saline injection in control group, acute hypoglycemia group (AHG), recurrent hypoglycemia group at day 1 (RHG day1) and at day 4 (RHG day 4).
Table (1):
The mean values ± SE of plasma epinephrine levels (pg/ml) in control group, acute hypoglycemia group (AHG), recurrent hypoglycemia group at day 1 (RHG day1) and at day 4 (RHG day 4) at baseline and 90 min after saline or insulin injection. 
Table (2):
The mean values ± SE and the percent changes in the plasma CK and LDH in control group, acute hypoglycemia group (AHG) and recurrent hypoglycemia group at day 4 (RHG day4) at baseline and 6 h after saline or insulin injection.
Enzymes Groups Baseline values 6 h after the injection 
DISCUSSION
In the present study insulin induced hypoglycemia resulted in a remarkable rise in plasma CK and LDH in AHG and RHG rats (day4) after 6 hours of insulin injection. CK and LDH are cytoplasmic enzymes, their plasma activity increased due to their leakage through membranes of damaged cells. CK is an enzyme which catalyses the reversible transfer of the phosphoryl group from phosphocreatine to ADP to regenerate ATP. Whereas, LDH is a key enzyme involved in the process of conversion of lactic acid to pyruvate (19) . 23,24) . Increased the plasma level of LDH is also considered a marker of skeletal and or cardiac muscle injury. This is because its highest activity found in skeletal muscles and heart (25, 26) . Accordingly, the increased in plasma CK and LDH levels found in this study suggests that either acute or recurrent hypoglycemia cause pathological damage to the skeletal muscles and or heart. Other previous studies demonstrated a remarkable rise in plasma CK and LDH by insulin induced hypoglycemia. In addition to increase the plasma levels of alanine aminotransferase(ALT), aspartate aminotransferase (AST), which are all primarily due to damage in skeletal muscles and heart.
Further, we studied the alteration of MDA and T-AOC levels in skeletal muscle and heart tissues after insulin induced hypoglycemia. MDA is a marker of lipid peroxidation, while T-AOC reflects the capacity for elimination of free radicals (29) . Significant increase of MDA and significant reduction of T-AOC levels in the skeletal muscle and heart tissues were found after 6 h of insulin injection in AHG and RHG (day 4) groups compared to control. These results indicate that either acute or recurrent insulin induced hypoglycemia is associated with oxidative stress. These results are comparable to other previous studies found that oxidative stress could be triggered by hypoglycemia. In the study of Patockova et al (30) it was observed that a significant increase of lipid peroxidation induced by insulin hypoglycemia in tissues of the brain and heart of mice, which provided the evidence of oxidative stress in those tissues. Additionally, in the study of Jiang et al. (28) it was found that administration of antioxidant as reduced glutathione prevented the increased serum enzymes following experimental hypoglycemia. Hyperinsulinemia had also been supposed to cause oxidative stress (31) . However, the after wards study of Patočková et al. showed that increase in lipid peroxidation is dependent on the severity of hypoglycemia but not on the insulin dosage.
Considerable evidence suggested that oxidative stress plays an important role in neuronal death associated with hypoglycemia (9,32) . This also had a role in other hypoglycemic tissues damage as liver, kidney (33) and the heart (30) . Oxidative damage to skeletal muscle and heart follow hypoglycemia is suggested in this study. This oxidative damage could be explained based on previous observation that during hypoglycemia, the skeletal muscles would be a target for glucose counter regulation in the periphery. First, by reduction of glucose uptake by muscles thus, makes more glucose available to the brain. Second, there is activation of glycogen phosphorylase and inhibition of glycogen synthase enzymes with mobilization of gluconeogenic substrates from glycogen stores in muscles to the liver (34, 35) . Prolonged insulin-induced hypoglycemia decreases the substrate supply for energy metabolism in muscles. A change in oxidation reduction in muscles consequently will result due to depletion of intracellular adenosine triphosphate (27) . Hypoglycemia may also suppress energy metabolism and increase ineffective glucose metabolism in the heart. It was reported that insulin induced hypoglycemia caused heart failure, angina pectoris and myocardial infarction. These effects were attributed to insufficient energy production for the increased left ventricular load (7,36) . In support of this, it was found that other conditions of energy impairment or failure such as ischemia or glycolysis inhibition also involves oxidative damage (37, 38) .Increased acidity during prolonged hypoglycemia occurs as a result of increased fatty acid metabolism. This will additionally augment free radical destructive effects (8,10) . In keeping with these data, the results of the current study demonstrate that either acute or recurrent insulin induced hypoglycemia caused energy impairment in skeletal muscle and heart. This produced oxidative stress to these tissues and resulted in oxidative damage to their cell membranes. Thus, providing a possible explanation of hypoglycemic damage affecting those tissues that was represented by increased plasma CK and LDH.
The present study demonstrates that, the increase in plasma levels of CK and LDH and their percent increase than baseline values were more obvious in RHG group (day 4) compared to those of AHG group. There was also more rise of MDA with more reduction of T-AOC levels in the skeletal muscle and heart tissues compared to AHG group. Presumably, these results were mediated by the significant decline in blood glucose levels in RHG group in day 4 when compared to either AHG or RHG group at day 1. This lower glucose levels is expected to cause more energy impairment and thus increased oxidative stress leading to more muscle and heart tissue damage represented by elevated plasma CK and LDH levels. This is supported by the study of Jiang et al. (27) finding that hypoglycemic organ damage including skeletal muscles and heart tends to increase in severity according to the severity of hypoglycemia.
The significant lower levels of blood glucose after insulin injection in RHG group (day 4) can be explained by the impaired epinephrine response reported in this group. Our results showed that after 90 min of the injection there were significant higher levels of epinephrine in AHG group, RHG group at day 1 than control levels. This increase is expected in response to hypoglycemia to counteract for the low blood glucose (39) . On the other hand, the levels detected in RHG group at day 4 were significantly less than control levels. This denotes that 3 days of insulin-induced hypoglycemia 40) . It is less certain how recurrent insulin-induced hypoglycemia with impaired epinephrine secretion impact at the peripheral tissue. Epinephrine exert some of its insulin antagonistic effects in the periphery by decreasing peripheral glucose uptake, mobilize substrates and fuel for gluconeogenesis, inhibit glucose metabolism in muscle and adipose tissue (41) . However, the critical role of epinephrine during hypoglycemia is in large part due to its potent lipolytic effect on skeletal muscle and adipose tissue. Although it is well known that adipose tissue is the principle source of lipid-derived fuel (NEFA and glycerol), it was found that there is significant intramuscular lipolysis as well (42) , According to this scenario, recurrent insulin induced hypoglycemia amplifies the potential for hypoglycemic damage by inhibiting epinephrine -induced lipolysis. Defective stimulation of lipolysis in skeletal muscle and adipose tissue is associated with an inappropriate increase in muscle and heart glucose disposal. These pathophysiological changes may be important contributors to the development of hypoglycemic muscle and heart damage following recurrent hypoglycemia (41) . In summary, there is evidence from the results of the present study and the fore mentioned discussion that acute and recurrent insulin induced hypoglycemia caused skeletal muscle and heart damage. That was represented by a significant increase in plasma CK and LDH levels. This could be explained by increased oxidative stress detected in those tissues that resulted from glucoprivation. The damaging effect is more evident following recurrent hypoglycemia which may be attributed to the suppressed epinephrine response to recurrent hypoglycemia causing more decrease in blood glucose and thus more damage to these tissues. 
